Novalar Pharmaceuticals' Seed Round

Novalar Pharmaceuticals raised a round of funding on October 01, 2000.

Novalar is developing a drug agent that is designed to reverse the effects of local anesthesia applied in dental procedures, thereby allowing patients to return to their daily activities without the s…

Articles about Novalar Pharmaceuticals' Seed Round: